A detailed history of Black Rock Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,743,002 shares of ARCT stock, worth $106 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,743,002
Previous 2,398,296 14.37%
Holding current value
$106 Million
Previous $75.6 Million 22.5%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$31.23 - $42.99 $10.8 Million - $14.8 Million
344,706 Added 14.37%
2,743,002 $92.6 Million
Q4 2023

Feb 13, 2024

BUY
$17.71 - $32.97 $4.62 Million - $8.59 Million
260,596 Added 12.19%
2,398,296 $75.6 Million
Q3 2023

Nov 13, 2023

BUY
$25.44 - $37.35 $3.7 Million - $5.43 Million
145,465 Added 7.3%
2,137,700 $54.6 Million
Q2 2023

Aug 11, 2023

BUY
$23.94 - $32.36 $4.69 Million - $6.34 Million
195,918 Added 10.91%
1,992,235 $57.1 Million
Q1 2023

May 12, 2023

SELL
$14.72 - $23.97 $1.3 Million - $2.12 Million
-88,568 Reduced 4.7%
1,796,317 $43.1 Million
Q4 2022

Feb 13, 2023

SELL
$14.14 - $23.06 $1.07 Million - $1.75 Million
-75,704 Reduced 3.86%
1,884,885 $32 Million
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $734,545 - $1.25 Million
56,287 Added 2.96%
1,960,589 $29.1 Million
Q2 2022

Aug 12, 2022

BUY
$12.26 - $31.17 $2.56 Million - $6.5 Million
208,663 Added 12.31%
1,904,302 $30 Million
Q1 2022

May 12, 2022

SELL
$17.64 - $39.57 $1.13 Million - $2.53 Million
-63,951 Reduced 3.63%
1,695,639 $45.7 Million
Q4 2021

Feb 10, 2022

BUY
$34.2 - $47.56 $1.33 Million - $1.85 Million
38,882 Added 2.26%
1,759,590 $65.1 Million
Q3 2021

Nov 09, 2021

BUY
$27.88 - $58.25 $479,508 - $1 Million
17,199 Added 1.01%
1,720,708 $82.2 Million
Q2 2021

Aug 11, 2021

BUY
$25.79 - $42.11 $43.9 Million - $71.7 Million
1,703,509 New
1,703,509 $57.6 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $1.03B
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.